Transforming Hemophilia A Treatment with Bispecific Antibodies – NEJM Group
NEJM Group shared a post on LinkedIn about a recent article by Flora Peyvandi, published in The New England Journal of Medicine, adding;
“Kunihiro Hattori, Tomoyuki Igawa, and Takehisa Kitazawa, who developed a prophylactic therapy for hemophilia A, have received the 2026 Lasker-DeBakey Clinical Medical Research Award.
For decades, the treatment of hemophilia A rested on a single principle: replacing factor VIII, the missing clotting factor.
Plasma-derived and recombinant factor VIII concentrates transformed a once-fatal disease into a manageable chronic condition through prophylaxis and treatment.
But factor VIII has a relatively short half-life and thus is administered through frequent intravenous infusions, and neutralizing anti-factor VIII antibodies (inhibitors) that render replacement therapy ineffective develop in up to one third of patients with severe hemophilia A.
By showing that the coagulation cascade could be activated in the absence of factor VIII, Kunihiro Hattori, Tomoyuki Igawa, and Takehisa Kitazawa (of Chugai Pharmaceutical) overcame these limitations.
They developed a bispecific antibody that mimics blood coagulation factor VIlI, an achievement recognized by the 2026 Lasker-DeBakey Clinical Medical Research Award.”
Title: Reengineering Coagulation with a Bispecific Antibody
Authors: Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?